Ipca Laboratories Ltd. - Research Center
524494 IPCALAB Group (A) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Sales | 3,149.01 | 2,954.16 | 2,496.92 | 2,902.44 | 2,143.86 |
| Operating profit | 606.51 | 529.39 | 490.54 | 753.00 | 458.16 |
| Interest | 69.40 | 15.80 | 4.48 | 2.73 | 7.27 |
| Gross profit | 616.41 | 568.99 | 513.51 | 778.95 | 481.82 |
| EPS (Rs) | 12.96 | 12.28 | 12.95 | 21.38 | 12.84 |
Half yearly
results in details
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Other income | 79.30 | 55.40 | 27.45 | 28.68 | 30.93 |
| Stock adjustment | -96.28 | -33.50 | -176.81 | 56.05 | -118.05 |
| Raw material | 913.74 | 905.62 | 792.48 | 808.50 | 721.69 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 668.64 | 591.94 | 532.35 | 557.28 | 445.60 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 1,056.40 | 960.71 | 858.36 | 727.61 | 636.46 |
| Provisions made | - | - | - | - | - |
| Depreciation | 121.70 | 108.33 | 103.64 | 100.46 | 91.54 |
| Taxation | 166.00 | 149.06 | 81.29 | 136.13 | 65.89 |
| Net profit / loss | 328.71 | 311.60 | 328.58 | 542.36 | 324.39 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 25.37 | 25.37 | 25.37 | 25.37 | 25.27 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 19.26 | 17.92 | 19.65 | 25.94 | 21.37 |
| GPM (%) | 19.09 | 18.91 | 20.34 | 26.58 | 22.15 |
| NPM (%) | 10.18 | 10.35 | 13.02 | 18.50 | 14.92 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis